CAJ | 학술논문

目的：研究尿毒症继发甲状旁腺功能亢进采用血透加灌流治疗的临床疗效。方法：随机抽取2012年2月～2013年6月本院接诊的45例尿毒症继发甲状旁腺功能亢进患者作为研究对象，将接受低钙透析液加活性维生素D3冲击治疗的患者（23例）归为对照组，将22例在对照组基础上增加HA型树脂血液灌流疗法的患者归为观察组。结果：治疗后观察组患者Ca（血钙）、P（血磷）、iPTH（甲状旁腺激素）及Ca×P（钙磷乘积）整体改善情况由于对照组；治疗后观察组患者18例（81.8％）肌无力、皮肤瘙痒症状得以有效缓解，对照组11例（47.8％）。结论：血透加灌流治疗尿毒症继发甲状旁腺功能亢进疗效显著，值得临床应用。
목적：연구뇨독증계발갑상방선공능항진채용혈투가관류치료적림상료효。방법：수궤추취2012년2월～2013년6월본원접진적45례뇨독증계발갑상방선공능항진환자작위연구대상，장접수저개투석액가활성유생소D3충격치료적환자（23례）귀위대조조，장22례재대조조기출상증가HA형수지혈액관류요법적환자귀위관찰조。결과：치료후관찰조환자Ca（혈개）、P（혈린）、iPTH（갑상방선격소）급Ca×P（개린승적）정체개선정황유우대조조；치료후관찰조환자18례（81.8％）기무력、피부소양증상득이유효완해，대조조11례（47.8％）。결론：혈투가관류치료뇨독증계발갑상방선공능항진료효현저，치득림상응용。
Objective:To study the clinical effect of uremic secondary hyperparathyroidism with hemodialysis and perfusion therapy. Methods:randomly selected in 2012 February~45 uremic secondary hyperparathyroidism patients in this hospital admissions in 2013 June as the research object, wil accept the low calcium dialysate and active Vitamin D3 shock treated patients (23 cases) classified as the control group, 22 cases in the control group based on the increase of HA type resin hemoperfusion therapy patients were classified as the observation group. Results:after the treatment, the patients in observation group were Ca (Xue Gai), P (phosphorus), iPTH (parathyroid hormone) and Ca*P (calcium phosphorus product) to improving the overal situation as control group;the observation group patients after the treatment of 18 cases of myasthenia gravis (81.8%), skin itching can be effectively al eviated, 11 cases in the control group (47.8%). Conclusion:the therapeutic effect of hemodialysis and perfusion flow in treatment of uremic secondary hyperparathyroidism is significant, worthy of clinical application.